Intuniv XR1Mg 100 tablets

Description

Intuniv XR (generic name: guanfacine) is a non-stimulant extended-release tablet used to treat Attention-deficit/Hyperactivity Disorder (ADHD) in children and adolescents aged 6 to 17 years. It belongs to the class of medicines called alpha-2A adrenergic agonists. Guanfacine works by strengthening regulation of attention and impulse control through its action on the prefrontal cortex. It can be taken alone or alongside stimulant medicines, providing symptom relief without the abuse potential of stimulants. Treatment is once daily, designed for steady coverage throughout the day. Learn more from MedlinePlus.

Usual dosage

It is important to follow the dosage instructions printed on the label of the box.The usual starting dose is 1 mg once daily, taken in the morning or evening. The dose may be increased by 1 mg per week depending on response, typically reaching 3–4 mg daily. The maximum dose is 4 mg/day in children 6–12 years and 7 mg/day in adolescents 13–17 years. Dosing may also be weight-based (0.05–0.12 mg/kg/day).

Tablets should be swallowed whole. Do not crush or chew. If a dose is missed, skip it and continue with the next scheduled dose. Do not double dose to make up for a missed dose.

Caution: do not discontinue abruptly, as this may cause rebound high blood pressure; taper gradually under medical advice.

Standard storage

Store Intuniv XR tablets at 20-25 °C (68-77 °F). Protect from moisture and light. Store in the original container with the cap closed.

Keep out of reach of children. Do not use beyond the expiry date, which refers to the last day of the month printed on the package.